Bonacchi Massimo, Prifti Edvin, Maiani Massimo, Giunti Gabriele, Leacche Marzia
Department of Cardiac Surgery, Cattedra e Scuola di Specializzazione in Cardiochirurgia, University of Florence, Viale Morgagni, 85, Careggi, 50134 Firenze, Italy.
Eur J Cardiothorac Surg. 2005 Jul;28(1):120-6. doi: 10.1016/j.ejcts.2005.03.031.
The aim of this study was to evaluate the feasibility, safety and outcome of skeletonized bilateral internal mammary arteries (BIMA) in patients with unstable angina (UA) undergoing non-elective myocardial revascularization.
Between January 1997 and December 2003, 758 patients, mean age 62+/-12 years, underwent non-elective coronary artery bypass grafting (CABG) for unstable angina. Two hundred and five (27%) were operated emergently and 503 (73%) urgently. BIMA were employed in 320 (42%) patients (Group B) and isolated left IMA and/or saphenous vein grafts in the remaining 438 (58%) patients (Group M).
In-hospital mortality (B = 5.9% and M = 5.3%), and perioperative myocardial infarction (B = 2.2%; M = 1.96%) were similar between the two groups (P = ns). Actuarial survival at 1, 3 and 7 years was 98.7, 97.5 and 96.2% in B and 99, 94.3 and 88.4% in M (P < 0.05 at 7 years follow-up). At 7 years follow-up, the event-free cardiac survival (92 vs. 87%, P = 0.021), angina-free survival (98.6 vs. 94%, P = 0.039), reoperation-free cardiac survival (98 vs. 95%, P = 0.04) and infarct-free cardiac survival (98.7 vs. 96%, P = 0.05) were better in Group B. Multivariate analysis identified age > 65 years (P = 0.02), LVEF < 35% (P = 0.01), > 1 ischemic irreversible area (P = 0.03) as independent predictors for late deaths, while the use of the LIMA (P=0.006) and both mammary arteries (P=0.001) decreased the risk of late deaths.
The use of BIMA in non-elective CABG for UA is safe and effective. Mid-term outcome, however, are superior with improved freedom from cardiac death, from coronary reintervention and from myocardial infarction.
本研究旨在评估在接受非选择性心肌血运重建的不稳定型心绞痛(UA)患者中,游离双侧乳内动脉(BIMA)的可行性、安全性及疗效。
1997年1月至2003年12月期间,758例平均年龄为62±12岁的患者因不稳定型心绞痛接受了非选择性冠状动脉旁路移植术(CABG)。其中205例(27%)为急诊手术,503例(73%)为紧急手术。320例(42%)患者采用了BIMA(B组),其余438例(58%)患者采用了单纯左乳内动脉和/或大隐静脉移植(M组)。
两组患者的院内死亡率(B组为5.9%,M组为5.3%)和围手术期心肌梗死发生率(B组为2.2%;M组为1.96%)相似(P = 无显著性差异)。B组1年、3年和7年的精算生存率分别为98.7%、97.5%和96.2%,M组分别为99%、94.3%和88.4%(随访7年时P < 0.05)。在7年随访时,B组的无事件心脏生存率(92%对87%,P = 0.021)、无心绞痛生存率(98.6%对94%,P = 0.039)、无再次手术心脏生存率(98%对95%,P = 0.04)和无梗死心脏生存率(98.7%对96%,P = 0.05)均优于M组。多因素分析确定年龄>65岁(P = 0.02)、左心室射血分数<35%(P = 0.01)、>1个缺血不可逆区域(P = 0.03)为晚期死亡的独立预测因素,而使用左乳内动脉(P = 0.006)和双侧乳内动脉(P = 0.001)可降低晚期死亡风险。
在UA患者的非选择性CABG中使用BIMA是安全有效的。然而,中期结果更佳,心脏死亡、冠状动脉再次干预和心肌梗死的发生率降低。